Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Praxis Precision Medicines Inc (PRAX)

18   -1.71 (-8.68%) 12-05 00:35
Open: 19.63 Pre. Close: 19.71
High: 19.98 Low: 17.61
Volume: 303,942 Market Cap: 807M
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement Purdue Neuroscience Company; and a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.996 - 20.097 20.097 - 20.162
Low: 17.392 - 17.513 17.513 - 17.591
Close: 17.824 - 18.009 18.009 - 18.128

Technical analysis

as of: 2021-12-03 4:46:00 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 23.75     One year: 26.74
Support: Support1: 16.19    Support2: 13.47
Resistance: Resistance1: 20.33    Resistance2: 22.89
Pivot: 18.22
Moving Average: MA(5): 17.81     MA(20): 18.94
MA(100): 18.80     MA(250): 28.95
MACD: MACD(12,26): -0.71     Signal(9): -0.70
Stochastic oscillator: %K(14,3): 43.09     %D(3): 30.42
RSI: RSI(14): 44.49
52-week: High: 60.95  Low: 12.71  Change(%): -59.4
Average Vol(K): 3-Month: 23224  10-Days: 33411

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PRAX has closed above bottom band by 44.3%. Bollinger Bands are 18.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 02 Dec 2021
Will Praxis Precision Medicines Inc (PRAX) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Mon, 29 Nov 2021
Praxis Precision Medicines to Present Data from Rare Disease Programs at the American Epilepsy Society 2021 Annual Meeting - GlobeNewswire

Wed, 24 Nov 2021
Praxis Precision Medicines to Present at Piper Sandler's 33rd Annual Virtual Healthcare Conference - The Bakersfield Californian

Wed, 03 Nov 2021
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results - Yahoo Finance

Wed, 01 Sep 2021
Praxis Precision Medicines to Present at Citi's 16th Annual - GlobeNewswire

Mon, 16 Aug 2021
Praxis Precision Medicines Shares Drop 6% After Results for Depression Treatment - MarketWatch

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 45
Shares Float (M) 35
% Held by Insiders 1.43
% Held by Institutions 94.11
Shares Short (K) 1,420
Shares Short P. Month (K) 1,360

Stock Financials

EPS -3.470
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 6.660
Profit Margin
Operating Margin
Return on Assets (ttm) -37.8
Return on Equity (ttm) -66.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.993
Qtrly Earnings Growth
Operating Cash Flow (M) -100
Levered Free Cash Flow (M) -53

Stock Valuations

PE Ratio -5.19
PEG Ratio
Price to Book value 2.70
Price to Sales
Price to Cash Flow -8.08

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.